EC wants Cad 3 study to look at bank lending to smaller companies

The European Commission said it launched a tender today for a study that would pay particular attention to the consequences for small and medium-sized enterprises (SMEs) of proposed new European Union (EU) banking capital rules.

The study of the EU’s third capital adequacy directive, or Cad 3, was requested by the European Council at its Barcelona meeting in March this year. Tenders must be with the Commission by October 10.

The Commission wants to introduce Cad 3 for all banks and investment firms in the 15-nation EU by late 2006, the planned date also for the implementation of the Basel II bank capital adequacy accord.

Cad 3 is closely modelled on the complex and risk-based Basel II accord, designed by global banking regulators to apply in the first instance to the large, internationally active banks of the world’s leading economies. Basel II will determine how much of their assets the banks must put aside to act as a cushion to absorb losses from banking hazards, including credit risk.

EU member-state Germany threatened to veto Basel II if it penalised lending to SMEs – regarded as the growth engine of the country’s economy – by requiring big banks to set aside more protective capital to guard against the risks of lending to such companies.

Germany lifted its objections in July after the Basel Committee on Banking Supervision, the architect of Basel II, agreed a compromise whereby capital charges on bank loans to SMEs would on average be 10% less than for loans to large firms.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here